Elevated blood pressure and heart rate in human renin receptor transgenic rats

被引:182
作者
Burcklé, CA
Danser, AHJ
Müller, DN
Garrelds, IM
Gasc, JM
Popova, E
Plehm, R
Peters, J
Bader, M
Nguyen, G
机构
[1] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
[2] INSERM, U36, Paris, France
[3] Coll France, Expt Med Unit, F-75231 Paris, France
[4] Franz Volhard Clin, Berlin, Germany
[5] Ernst Moritz Arndt Univ Greifswald, Inst Physiol, Greifswald, Germany
[6] Erasmus MC, Dept Pharmacol, Rotterdam, Netherlands
关键词
renin; rats; transgenic; blood pressure;
D O I
10.1161/01.HYP.0000199912.47657.04
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Recently, a receptor for renin was described that may be important for vascular uptake and activation of (pro) renin, thus leading to local generation of angiotensin II. To assess the in vivo relevance of this protein, we generated transgenic rats overexpressing the human renin receptor gene in smooth muscle tissue, under the control of a 16-kb fragment of the mouse smooth muscle myosin heavy chain gene [TGR(SMMHC-HRR)]. Four lines of transgenic animals were obtained. The correct pattern of expression of the transgene was confirmed by RNase protection assay and in situ hybridization. TGR(SMMHC-HRR) rats are fertile and develop normally. After 6 months of age, transgenic rats develop a cardiovascular phenotype with an elevated systolic blood pressure (137.8 +/- 5 versus 118.9 +/- 3.7 mm Hg; P = 0.008), and an augmentation in heart rate (349.1 +/- 7.7 versus 303.1 +/- 16.16 bpm; P = 0.023) in TGR(SMMHC-HRR) and controls, respectively. These alterations are progressively increasing with aging. Although kidney function and plasma renin were normal in TGR(SMMHC-HRR), an increase in plasma aldosterone [TGR(SMMHC-HRR) 428 +/- 64.9 versus 207.3 +/- 73.24 pg/mL in control; P = 0.02] and in aldosterone/renin ratio [TGR(SMMHC-HRR) 8.04 +/- 2.2 versus 2.8 +/- 0.55 in control; P = 0.03] was observed. This suggests that renin receptor overexpression has resulted in increased intraadrenal angiotensin II, thereby provoking enhanced aldosterone generation in the absence of changes in plasma renin. The rise in aldosterone may underlie, at least in part, the observed cardiovascular phenotype of TGR(SMMHC-HRR).
引用
收藏
页码:552 / 556
页数:5
相关论文
共 17 条
[1]   Identification of 315 genes essential for early zebrafish development [J].
Amsterdam, A ;
Nissen, RM ;
Sun, ZX ;
Swindell, EC ;
Farrington, S ;
Hopkins, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (35) :12792-12797
[2]   CARDIAC RENIN AND ANGIOTENSINS - UPTAKE FROM PLASMA VERSUS IN-SITU SYNTHESIS [J].
DANSER, AHJ ;
VANKATS, JP ;
ADMIRAAL, PJJ ;
DERKS, FHM ;
LAMERS, JMJ ;
VERDOUW, PD ;
SAXENA, PR ;
SCHALEKAMP, MADH .
HYPERTENSION, 1994, 24 (01) :37-48
[3]   Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle'' region for nonproteolytic activation of prorenin [J].
Ichihara, A ;
Hayashi, M ;
Kaneshiro, Y ;
Suzuki, F ;
Nakagawa, T ;
Tada, Y ;
Koura, Y ;
Nishiyama, A ;
Okada, H ;
Uddin, MN ;
Nabi, AHMN ;
Ishida, Y ;
Inagami, T ;
Saruta, T .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (08) :1128-1135
[4]   Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules [J].
Ludwig, J ;
Kerscher, S ;
Brandt, U ;
Pfeiffer, K ;
Getlawi, F ;
Apps, DK ;
Schägger, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (18) :10939-10947
[5]   INCREASED PLASMA INACTIVE RENIN IN DIABETES-MELLITUS - A MARKER OF MICROVASCULAR COMPLICATIONS [J].
LUETSCHER, JA ;
KRAEMER, FB ;
WILSON, DM ;
SCHWARTZ, HC ;
BRYERASH, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (22) :1412-1417
[6]  
Madsen CS, 1998, CIRC RES, V82, P908
[7]   Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin [J].
Nguyen, G ;
Delarue, F ;
Burcklé, C ;
Bouzhir, L ;
Giller, T ;
Sraer, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (11) :1417-1427
[8]   Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats [J].
Pilz, B ;
Shagdarsuren, E ;
Wellner, M ;
Fiebeler, A ;
Dechend, R ;
Gratze, P ;
Meiners, S ;
Feldman, DL ;
Webb, RL ;
Garrelds, IM ;
Danser, AHJ ;
Luft, FC ;
Müller, DN .
HYPERTENSION, 2005, 46 (03) :569-576
[9]  
PLEHM R, IN PRESS METHODS MOL
[10]  
Popova E, 2005, METH MOLEC MED, V108, P33